All News

The panelists reviewed current treatments for Clostridioides difficile infection and how they can be applied to special patient populations, as well as what treatments can be expected in the future.

Rivaroxaban and apixaban are the most commonly prescribed direct oral anticoagulants, although they may be most effective in different populations.

Lodise discussed key points from the guidance, current regimen recommendations, and clinical scenarios where therapy recommendations outside of the guidelines might be considered.

Despite how it is sometimes portrayed in pop culture, chickenpox is far from funny and is, in fact, preventable.

The analysis showed that the synchronization of bilateral anterior temporal and right central EEG signals in β-band tended to decrease for individuals with acute herpes zoster.

As some of the nation’s leading pharmaceutical and biotech giants ramp up product development and commercialization, what was once a futuristic concept has become a reality.

Amid the current shortage in the pharmacy technician workforce, career ladder programs could improve pharmacy technician recruitment and retention rates.

Using a non-aqueous vehicle and sweeteners to improve palatability, pharmacists and technicians can ensure that young patients remain medication adherent.

Results highlight sustained benefits of avapritinib in patients with advanced systemic mastocytosis.

Ten quiz questions to assess your knowledge on common symptoms and treatments for endometrial cancer.

Families and providers can use a flexible infusion schedule to meet patient needs, Octapharma says.

Ayr helps add moisture inside the nose to dissolve and soften thick or crusty mucus.

Tepotinib treats adult patients with metastatic non-small cell lung cancer harboring a mesenchymal epithelial transition exon 14 skipping alteration.

Fibromuscular dysplasia typically appears in the arteries leading to the kidneys and brain.

Help patients prepare for these winter ailments and choose the appropriate nonprescription medications.

Assessing stroke benefit and net clinical benefit of anticoagulation is essential in patients with end-stage renal disease and atrial fibrillation.

Genomic analyses show promise for patients with metastatic breast cancer, reinforcing genomics as a part of the pathway of care.

Tamoxifen is given to many patients—specifically premenopausal patients—with breast cancers that express the estrogen receptor, which drives breast tumor growth.

Patients ages 80 and older have unique considerations when deciding whether to initiate anticoagulation therapy.

Moderna COVID-19 vaccine found to offer an increased level of protection, including a 21% reduced risk of documented infection and 41% lower risk of hospitalization.

In part 2 of the discussion, Lodise said the decision of which drugs to use for various infections is very nuanced, but the new guidance document utilized the best available evidence.

Certain patients with breast cancer treated with an aromatase inhibitor plus palbociclib (Ibrance) could benefit from an early switch to fulvestrant (Faslodex) plus palbociclib, study finds.

Pyrotinib combined with capecitabine found to improve overall survival in patients with previously treated HER2-positive metastatic breast cancer.

Phase 3 induction study results show that the drug achieved a positive endoscopic response at week 12

Administered 6 months after the 2-dose regimen of BNT162b2, boosting with the Johnson & Johnson vaccine shows a substantial increase in antibody and T-cell responses.

Zarbee’s contains vitamin C, vitamin D, and zinc.

Rylaze is a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma.

Thomas Lodise, PharmD, PhD, discussed new guidance released by the Infectious Diseases Society of America (IDSA) on the treatment of antimicrobial resistant gram-negative infections.

A baby with fetal macrosomia weighs more than 8 pounds, 13 ounces.

In the case reviewed, the pharmacy department created an interdisciplinary Biosimilar Task Force responsible for making decisions relating to the adoption of biosimilar therapies.